Camp4 Therapeutics (CAMP) Long-Term Deferred Tax (2024)

Camp4 Therapeutics (CAMP) reported Long-Term Deferred Tax of $3.3 million for Q3 2024.

Camp4 Therapeutics (CAMP) Long-Term Deferred Tax (2024) Analysis & Trends

Camp4 Therapeutics (CAMP) has 1 years of Long-Term Deferred Tax data on file, last reported at $3.3 million in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Camp4 Therapeutics	174.35 Mn	174.35 Mn	-

Download Data

Date	Value
Sep 30, 2024	3.32 Mn